Redeye comments on Ngenic’s intention to divest its subsidiary Ngenic Sweden AB to Nordic Propeye fo...
The Human Research Ethics Committee (HREC) has provided the green light to commence enrolment for Me...
Redeye comments on Thunderful Group’s divestment of Headup.
Pricer has updated its financial targets Sales +15% p.
Minor estimate revisions Expect primarily volume-driven growth FVR of SEK 20-35 reiterated What to ...
Den virtuella satellitsnätsoperatören Wyld Networks ("Wyld") har påbörjat leverans av produkter unde...
Redeye trims its forecasts for Q1 2024 slightly while retaining its Base Case and comments on the FT...
In Q4-23, Movinn A/S (“Movinn” or the “Company”) continued to be affected by high vacancy rates, whi...
Windon Energy Group meddelade den 27 mars år 2024 att bolaget har ingått ett partnerskap i Norge med...
2024 förväntas bli ett övergångsår men de långsiktiga tillväxtutsikterna framstår som goda.
Cantargia today reported the preparations for the clinical trial of nadunolimab in leukaemia is goin...
Last week, Cibus issued green notes of EUR 80m and SEK 700m and launched a tender offer for bonds ma...
Bolaget presenterar vägen framåt I samband med bolagets kapitalmarknadsdag presenterades nya finansi...
Redeye comments on Freemelt’s new order from Saab Dynamics.
Sivers has announced the resignation of CEO Anders Strom, who is leaving his position to pursue new ...
ChargePanel AB (”ChargePanel” eller ”Bolaget”) har under helåret 2023 uppvisat en hög aktivitet geno...
Redeye briefly comments on BeammWave's rights issue.
IRLAB Therapeutics has confirmed the FDA’s alignment with its proposed Phase III programme for mesdo...
Inga större ordrar under Q1’24 och tuffa jämförelsetal Under H1’24 möter MilDef tuffa jämförelsetal.
On Friday, TH1NG announced the divestment of its broadband customers to Bahnhof.